News
Tiny Health and Bristle Health Launch Groundbreaking Study on Oral-Gut Health Connection
3+ mon, 4+ week ago (177+ words) AUSTIN, Texas, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Tiny Health and Bristle Health are recruiting participants for a pioneering'research study examining the connection between oral and gut health. The study offers participants comprehensive microbiome testing at exclusive research pricing while contributing to scientific…...
Vantive Presents New Data at WCN on How Coordinated Care Ecosystems Can Expand Home-Based Peritoneal Dialysis Access and Improve Patient Outcomes
1+ week, 6+ day ago (745+ words) Nephroprotection and early intervention support more planned dialysis starts, improved patient outcomes and increased use of home therapies, accor. .. Vantive Presents New Data at WCN on How Coordinated Care Ecosystems Can Expand Home-Based Peritoneal Dialysis Access and Improve Patient Outcomes…...
Press Release: Sanofi's Rezurock approved in the EU to treat chronic graft-vs-host disease
2+ week, 3+ hour ago (282+ words) Sanofi's Rezurock approved in the EU to treat chronic graft-vs-host disease The medicine was designated "orphan' (a medicine used in rare diseases) in 2019 for the treatment of graft-versus-host disease. Following this conditional marketing authorisation, the Committee for Orphan Medicinal Products…...
Mesoblast Receives IND Clearance from FDA to Directly Proceed to Registrational Trial for Approval of Ryoncil" in Duchenne Muscular Dystrophy
6+ day, 4+ hour ago (174+ words) Partnering with Parent Project Muscular Dystrophy to ensure timely access to the trial for eligible patients ~15, 000 children are living with DMD in the U. S. "We are very pleased to have received clearance to proceed directly to a registrational study for DMD…...
Press Release: Acoziborole Winthrop, developed by DNDi and Sanofi, receives CHMP positive opinion as three-tablet, single-dose treatment for most common form of sleeping sickness
1+ mon, 2+ week ago (316+ words) Acoziborole Winthrop, developed by DNDi and Sanofi, receives CHMP positive opinion as three-tablet, single-dose treatment for most common form of sleeping sickness" Kinshasa / Paris / Geneva / Amsterdam " February 27, 2026."The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has…...
Mesoblast Receives IND Clearance From FDA to Directly Proceed to Registrational Trial for Approval of Ryoncil" in Duchenne Muscular Dystrophy - CORRECTION
3+ day, 12+ hour ago (340+ words) Working with Parent Project Muscular Dystrophy and the Duchenne Registry on patient identification and trial awareness efforts" ~15, 000 children are living with DMD in the U. S. "We are very pleased to have received clearance to proceed directly to a registrational study for…...
Weight Watchers Launches Eli Lilly and Company's New Oral GLP-1 Foundayo" Available Through Lilly Direct
4+ day, 6+ hour ago (473+ words) WW International, Inc. (NASDAQ: WW) (Weight Watchers), the global leader in science-backed weight management, announced that it is now offering access to Eli Lilly and Company's newly FDA-approved. .. Weight Watchers Launches Eli Lilly and Company's New Oral GLP-1 Foundayo" Available…...
Acoramidis Significantly Reduces the Risk of All-Cause and Cardiovascular Mortality in Patients with ATTR-CM through Month 54
2+ week, 23+ min ago (225+ words) - Earliest timepoint in an open-label extension with this magnitude of risk reduction at 44. 7% in ACM (p - Acoramidis mitigated the rise in NT-pro BNP through Month 54 to an extent not seen in the era of disease modifying treatments - Early and continuous…...
Emergent Bio Solutions Partners with British Columbia to Supply NARCAN" Nasal Spray for the Launch of the Expanded BC Take Home Naloxone Program
3+ day, 23+ hour ago (160+ words) Learn more about Emergent's commitment to help combat the opioid crisis in'Canada'via this'National Impact Map. About NARCAN " 'Nasal Spray NARCAN'Nasal Spray is a pure opioid antagonist indicated for emergency use to reverse known or suspected opioid overdose, as manifested by…...
Emergent Bio Solutions Receives U. S. FDA Approval on Supplemental New Drug Application for NARCAN" Nasal Spray to be Packaged in a New Carrying Case, Making Life-Saving Naloxone More Accessible for. ..
2+ mon, 4+ week ago (394+ words) Since the U. S. prescription launch of NARCAN" Nasal Spray in 2016, the medicine has been trusted as a safe, effective way to reverse opioid overdoses, and today, new solutions like the NARCAN" carrying case aims to make accessibility paramount - "Trusted Then. Trusted…...